3-iodobenzylguanidine has been researched along with Wallerian Degeneration in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arai, N; Kanazawa, I; Mitsui, J; Momose, T; Murayama, S; Saito, Y; Shibahara, J; Shimizu, J; Tsuji, S; Ugawa, Y | 1 |
1 other study(ies) available for 3-iodobenzylguanidine and Wallerian Degeneration
Article | Year |
---|---|
Pathology of the sympathetic nervous system corresponding to the decreased cardiac uptake in 123I-metaiodobenzylguanidine (MIBG) scintigraphy in a patient with Parkinson disease.
Topics: 3-Iodobenzylguanidine; Aged; alpha-Synuclein; Autonomic Nervous System Diseases; Ganglia, Sympathetic; Heart; Humans; Iodine Radioisotopes; Lewy Bodies; Male; Myocardium; Norepinephrine; Parkinson Disease; Radionuclide Imaging; Spinal Cord; Sympathetic Fibers, Postganglionic; Sympathetic Nervous System; Wallerian Degeneration | 2006 |